RAŠKA, Jan, Hana HŘÍBKOVÁ, Hana KLÍMOVÁ, Veronika FEDOROVÁ, Martin BARÁK, Tomáš BÁRTA, Veronika POSPÍŠILOVÁ, Simona VOCHYÁNOVÁ, Tereza VÁŇOVÁ and Dáša BOHAČIAKOVÁ. Generation of six human iPSC lines from patients with a familial Alzheimer's disease (n=3) and sex- and age-matched healthy controls (n=3). Stem cell research. Amsterdam: Elsevier, 2021, vol. 53, May 2021, p. 1-5. ISSN 1873-5061. Available from: https://dx.doi.org/10.1016/j.scr.2021.102379.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Generation of six human iPSC lines from patients with a familial Alzheimer's disease (n=3) and sex- and age-matched healthy controls (n=3)
Authors RAŠKA, Jan (203 Czech Republic, belonging to the institution), Hana HŘÍBKOVÁ (203 Czech Republic, belonging to the institution), Hana KLÍMOVÁ (203 Czech Republic, belonging to the institution), Veronika FEDOROVÁ (203 Czech Republic, belonging to the institution), Martin BARÁK (203 Czech Republic, belonging to the institution), Tomáš BÁRTA (203 Czech Republic, belonging to the institution), Veronika POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution), Simona VOCHYÁNOVÁ (203 Czech Republic, belonging to the institution), Tereza VÁŇOVÁ (203 Czech Republic, belonging to the institution) and Dáša BOHAČIAKOVÁ (703 Slovakia, guarantor, belonging to the institution).
Edition Stem cell research, Amsterdam, Elsevier, 2021, 1873-5061.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10601 Cell biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.587
RIV identification code RIV/00216224:14110/21:00120161
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.scr.2021.102379
UT WoS 000656247000011
Keywords in English six human iPSC lines; Alzheimer's disease; healthy controls
Tags 14110517, CF CELLIM, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 21/2/2022 10:37.
Abstract
Human induced pluripotent stem cell (iPSC) lines were generated from primary human fibroblasts isolated from three patients with a familial form of Alzheimer's disease (AD) and three healthy control individuals. Two AD-iPSC lines carry a PSEN1 mutation A246E; the third cell line carries a PSEN2 mutation N141I. The fibroblasts were reprogrammed with Yamanaka factors (OSKM) using a commercially available Epi5 Reprogramming Kit. The pluripotency of iPSCs was confirmed by the expression of pluripotency factors and by their ability to differentiate to all three germ layers in vitro. Newly derived cell lines can be used to model Alzheimer's disease in vitro.
Links
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
LM2018129, research and development projectName: Národní infrastruktura pro biologické a medicínské zobrazování Czech-BioImaging
Investor: Ministry of Education, Youth and Sports of the CR
MUNI/A/1382/2019, interní kód MUName: Zdroje pro tkáňové inženýrství 10 (Acronym: TissueEng 10)
Investor: Masaryk University, Category A
MUNI/A/1689/2020, interní kód MUName: Zdroje pro tkáňové inženýrství 11 (Acronym: TissueEng 11)
Investor: Masaryk University
MUNI/G/1131/2017, interní kód MUName: Transformative stem cell-based model of Alzheimer’s disease and advanced analytics to study the role of membrane lipids in the pathogenesis
Investor: Masaryk University, INTERDISCIPLINARY - Interdisciplinary research projects
MUNI/R/1697/2020, interní kód MUName: Career Restart - Stem Cell-Based Models of Neurodegeneration
Investor: Masaryk University, CAREER RESTART
NV19-08-00472, research and development projectName: Klinicky relevantní biochemické, imunologické a buněčné biomarkery Alzheimerovy nemoci a stárnutí (Acronym: BioMAD)
Investor: Ministry of Health of the CR
ROZV/23/LF19/2019, interní kód MUName: Využití in vitro kultivovaných cerebrálních organoidů pro modelování patogeneze Alzheimerovy choroby
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
ROZV/28/LF22/2020, interní kód MUName: ln vitro modelováni Alzheimerovy choroby pomoci nově derivovaných indukovaných plunpotentnich kmenových buněk z pacientu se spontánní formou onemocnění.
Investor: Ministry of Education, Youth and Sports of the CR, Internal development projects
PrintDisplayed: 16/7/2024 23:47